Law360 (November 15, 2006, 12:00 AM EST) -- Cobalt Laboratories Inc. has become the third generics maker in the past five weeks to settle litigation with GlaxoSmithKline over the patent for the migraine treatment Imitrex.
Cobalt Laboratories Inc., an...
Generics Maker Settles Imitrex Suit With Glaxo
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
